What To Know: According to a Wall Street Journal report, the deal, which could be finalized by the end of 2023, would create a new major player in the industry, leveraging Cigna's pharmacy-benefit unit and commercial insurance capabilities and Humana's Medicare segment.

However, the potential of such a new health insurance powerhouse may also pose a threat to CVS as an established leader in the industry. Shares of CVS stock fell roughly 3% on Wednesday, possibly due to the news.

CVS stock has largely struggled over the past year, with shares down 27.89% year-to-date.

Related Link: What's Going On With Apple Stock?

CVS Price Action: Shares of CVS were down 3.09% at $67.18 at the time of publication, according to Benzinga Pro. 

Image by Charles Thompson from Pixabay